Apex Technology Acquisition Corp. (NASDAQ: APXT) and AvePoint Will Make a Donation to Girls Who Code for Every Shareholder who Votes on the Business Combination, up to $100,000 Total

BURLINGAME, Calif. & JERSEY CITY, N.J., June 22, 2021-- Apex Technology Acquisition Corp. ("Apex" or "the Company") (NASDAQ: APXT), a publicly traded special purpose acquisition company, encourages every stockholder to vote their shares in favor of the of the company’s proposed business combination with AvePoint, Inc. ("AvePoint"), and to vote FOR all the related proposals described in the company’s definitive proxy statement dated June 2, 2021 (the "Proxy Statement"). The related proposals are necessary to properly approve the business combination.

Apex and AvePoint will donate $1 for every shareholder who votes before June 30, up to $100,000 total, to Girls Who Code. The nonprofit organization’s mission is to close the gender gap in technology. Apex and AvePoint believe that the future of STEM is rooted in future generations where diversity is a strength that will set extraordinary organizations apart from the ordinary. The donations will be made for each vote cast, regardless of the content of the vote.

“Through AvePoint’s forward-looking position on aggressive, competitive and inclusive technology advancement, supporting Girls Who Code can help create a more equitable future for generations to come,” said Dr. Tianyi “TJ” Jiang, CEO of AvePoint.

In order to be counted, all votes must be submitted on or prior to June 30. The Board of Directors of Apex has recommended that stockholders vote FOR all 6 proposals and subparts. Stockholders of record of Apex common stock as of the close of business on the record date of June 1, 2021 may vote at or before the Special Meeting.

Stockholders should vote their shares, no matter how many shares they own. Every vote counts! If you need assistance voting your shares, please visit www.voteapxt.com or contact Apex’s proxy solicitor, MacKenzie Partners, Inc. by telephone at 1-888-410-7851 or by email at proxy@mackenziepartners.com.

All product and company names herein may be trademarks of their registered owners.